MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
|
Back to Search Results |
|
Model Number 8637-40 |
Device Problem
Insufficient Information (3190)
|
Patient Problems
Low Blood Pressure/ Hypotension (1914); Itching Sensation (1943); Muscular Rigidity (1968); Tachycardia (2095)
|
Event Date 12/27/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from multiple sources (manufacturer representative, healthcare provider) regarding a patient who was receiving lioresal with concentration 2000mcg/ml at a dose rate of 430mcg/day via an implantable pump.It was reported that patient was brought into the emergency department with symptoms of acute baclofen withdrawal.The patient was itchy without rash, had increased spasticity, a high heart rate, and low blood pressure.The patient was brought into the operating room. the pump was disconnected and the catheter was aspirated. a dye study was done and the catheter was found to be patent.The physician made the decision to change the pump.The patient's symptoms were improved the following morning ((b)(6) 2020). the issue was resolved as of (b)(6) 2020. the patient was without injury regarding their status as of (b)(6) 2020. the hospital was in possession of the pump which was to be returned to the manufacturer.The patient's medical history was noted as having been requested but would not be made available. it was noted that the healthcare provider had no further information regarding the event.
|
|
Event Description
|
Additional information received reported that the patient had a sudden loss of therapy.No rotor study or dye study was performed.The patient recovered without sequela.It was unclear the type of baclofen the pump was used to deliver at the time of the event as the return paperwork indicated compounded baclofen and interrogation of the pump upon return had baclofen.
|
|
Manufacturer Narrative
|
H3: analysis results were not available at the time of this report.A follow-up report will be sent when analysis is completed.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
H3 ¿ analysis of the pump found no anomaly.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|